Accumulative prediction values of serum thyroid stimulating hormone and visceral adipose tissue for metabolic syndrome in postmenopausal women: A 10-year follow-up study of Chinese population

被引:2
作者
Yang, Qiu [1 ]
Cao, Hongyi [1 ]
Zeng, Qi [2 ]
Fu, Bing [3 ]
机构
[1] Chengdu Fifth Peoples Hosp, Geriatr Dis Inst Chengdu, Ctr Med Res & Translat, Dept endocrinol, Chengdu, Peoples R China
[2] Chengdu Fifth Peoples Hosp, Informat Ctr, Chengdu, Peoples R China
[3] Chengdu Fifth Peoples Hosp, Geriatr Dis Inst Chengdu, Dept Radiol, POB 61113, Chengdu, Peoples R China
关键词
metabolic syndrome; thyroid stimulating hormone; visceral fat area; magnetic resonance imaging; postmenopausal; RISK-FACTORS; INSULIN-RESISTANCE; THYROTROPIN LEVELS; GLUCOSE-TOLERANCE; OBESITY; FAT; ASSOCIATION; PREVALENCE; PATHOPHYSIOLOGY; TESTOSTERONE;
D O I
10.1111/1753-0407.13472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: We aim to explore the cumulative predictive value of elevated serum thyroid stimulating hormone (TSH) and visceral fat area (VFA) for metabolic syndrome (MS) development in postmenopausal women. Methods: A total of 1006 postmenopausal females were enrolled in a 10-year prospective longitudinal study from 2011 to 2021 in the community of Bank-note Printing Company of Chengdu. The sociodemographic information collection and anthropometric measurements were made by a professional nurse. Fasting blood samples were drawn for chemical analysis of fasting plasma glucose, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and TSH. Magnetic resonance imaging was performed to measure VFA. All the participants were categorized into four groups according to median VFA and serum level of TSH. Results: A total of 793 postmenopausal females without MS underwent a 10-year follow-up study grouping by TSH and VFA: Group 1 (TSH level <4.2 mu IU/mL, and VFA < 70 cm(2)), Group 2 (TSH level >= 4.2 mu IU/mL, and VFA < 70 cm(2)), Group 3 (TSH level <4.2 mu IU/mL, and VFA <70 cm(2)) and Group 4 (TSH level <4.2 mu IU/mL, and VFA >= 70 cm(2)). During the 10-year follow-up, MS was newly developed in 326 (41.1%) subjects. The incidence of MS was 29.8% (n = 53), 35.2% (n = 63), 41% (n = 87), and 55% ( n = 123) from Group 1 to Group 4 (Group 4 vs other groups, p <.001). Cox regression analysis for MS prediction demonstrated that both TSH (Model 3, hazard ratio [HR] = 1.07 [95% confidence interval, 1.05-1.09]) and VFA (Model 4, HR = 1.02 [95% confidence interval, 1.01-1.08]) were not only independent predictors of MS but also involved some interaction between each other (p for interaction =.021). Conclusion: Our findings suggested that mutual interaction between higher TSH and VFA contributed to the development of MS. Further studies are needed to clarify these contributions.
引用
收藏
页数:10
相关论文
共 53 条
[1]   Obesity and Menopause [J].
Al-Safi, Zain A. ;
Polotsky, Alex J. .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2015, 29 (04) :548-553
[2]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[3]   Subclinical Disease Burden as Assessed by Whole-Body MRI in Subjects With Prediabetes, Subjects With Diabetes, and Normal Control Subjects From the General Population: The KORA-MRI Study [J].
Bamberg, Fabian ;
Hetterich, Holger ;
Rospleszcz, Susanne ;
Lorbeer, Roberto ;
Auweter, Sigrid D. ;
Schlett, Christopher L. ;
Schafnitzel, Anina ;
Bayerl, Christian ;
Schindler, Andreas ;
Saam, Tobias ;
Mueller-Peltzer, Katharina ;
Sommer, Wieland ;
Zitzelsberger, Tanja ;
Machann, Juergen ;
Ingrisch, Michael ;
Selder, Sonja ;
Rathmann, Wolfgang ;
Heier, Margit ;
Linkohr, Birgit ;
Meisinger, Christa ;
Weber, Christian ;
Ertl-Wagner, Birgit ;
Massberg, Steffen ;
Reiser, Maximilian F. ;
Peters, Annette .
DIABETES, 2017, 66 (01) :158-169
[4]   Prevalence and Trends of Metabolic Syndrome in the Adult U.S. Population, 1999-2010 [J].
Beltran-Sanchez, Hiram ;
Harhay, Michael O. ;
Harhay, Meera M. ;
McElligott, Sean .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (08) :697-703
[5]   Thyrotropin Levels, Insulin Resistance, and Metabolic Syndrome: A Cross-Sectional Analysis in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) [J].
Bensenor, Isabela M. ;
Goulart, Alessandra Carvalho ;
Molina, Maria del Carmen B. ;
Peixoto de Miranda, Erique Jose ;
Santos, Itamar S. ;
Lotufo, Paulo A. .
METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (08) :362-369
[6]   Central role of the adipocyte in the metabolic syndrome [J].
Bergman, RN ;
Van Citters, GW ;
Mittelman, SD ;
Dea, MK ;
Hamilton-Wessler, M ;
Kim, SP ;
Ellmerer, M .
JOURNAL OF INVESTIGATIVE MEDICINE, 2001, 49 (01) :119-126
[7]   PORTAL ADIPOSE-TISSUE AS A GENERATOR OF RISK-FACTORS FOR CARDIOVASCULAR-DISEASE AND DIABETES [J].
BJORNTORP, P .
ARTERIOSCLEROSIS, 1990, 10 (04) :493-496
[8]   An Approach for Development of Age-, Gender-, and Ethnicity-Specific Thyrotropin Reference Limits [J].
Boucai, Laura ;
Hollowell, Joseph G. ;
Surks, Martin I. .
THYROID, 2011, 21 (01) :5-11
[9]   A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition [J].
Burger, HG ;
Dudley, EC ;
Cui, JS ;
Dennerstein, L ;
Hopper, JL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08) :2832-2838
[10]   A longitudinal study of weight and the menopause transition: Results from the Massachusetts Women's Health Study [J].
Crawford, SL ;
Casey, VA ;
Avis, NE ;
McKinlay, SM .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2000, 7 (02) :96-104